TC1 (ATCC® CRL-2493)

Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)  /  Cell Type: hybridoma:lymphoblast B lymphocyte; somatic cell hybri  / 

Permits and Restrictions

View Permits View Restrictions

Organism Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type hybridoma:lymphoblast B lymphocyte; somatic cell hybri
Product Format frozen
Morphology lymphoblast
Culture Properties suspension, suspension
Biosafety Level 1
Applications
The antibody binds specifically for the exotoxin A of Pseudomonas aeruginosa.
It displays specificity for SDS-denatured exotoxin A from the strain PA103 and its derivative PA103/29 but does not react with exotoxin from strain PAO1 or its derivative PAO-PR1.
The antibody shows high specificity and reactivity for denatured exotoxin A in immunoblotting and ELISA assays.
Both TC1 (ATCC CRL-2493) and TC31 (ATCC CRL-2494) antibodies neutralize exotoxin A toxicity against CHO cells in an in vitro assay but only TC31 protected mice infected with strain PA220 in an in vivo model.
Storage Conditions liquid nitrogen vapor phase
Derivation
Animals were immunized with purified exotoxin A of Pseudomonas aeruginosa.
Spleen cells were fused with Sp2/0-Ag14 cells.
It displays specificity for SDS-denatured exotoxin A from the strain PA103 and its derivative PA103/29 but does not react with exotoxin from strain PAO1 or its derivative PAO-PR1.
Genes Expressed
immunoglobulin; monoclonal antibody; against an idiotypic determinant on TC-31 monoclonal antibody (against exotoxin A)
Cellular Products
immunoglobulin; monoclonal antibody; against an idiotypic determinant on TC-31 monoclonal antibody (against exotoxin A)
Comments
Animals were immunized with purified exotoxin A of Pseudomonas aeruginosa.
Spleen cells were fused with Sp2/0-Ag14 cells.
The antibody binds specifically for the exotoxin A of Pseudomonas aeruginosa.
It displays specificity for SDS-denatured exotoxin A from the strain PA103 and its derivative PA103/29 but does not react with exotoxin from strain PAO1 or its derivative PAO-PR1.
The antibody shows high specificity and reactivity for denatured exotoxin A in immunoblotting and ELISA assays.
Both TC1 (ATCC CRL-2493) and TC31 (ATCC CRL-2494) antibodies neutralize exotoxin A toxicity against CHO cells in an in vitro assay but only TC31 protected mice infected with strain PA220 in an in vivo model.
Complete Growth Medium Iscove's modified Dulbecco's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 85%; fetal bovine serum, 15%
Subculturing
Protocol: Cultures can be maintained by addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 5 X 10(4) viable cells/ml. Do not allow the cell concentration to exceed 5 X 10(5) viable cells/ml.
Interval: Maintain cultures at a cell concentration between 5 x 10(4) and 5 X 10(5) cells/ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Cryopreservation
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Culture Conditions
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Isotype mouse IgG1 kappa , IgG1; kappa light chain
Name of Depositor DG Sieckmann
Year of Origin 1984
References

Galloway DR, et al. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 44: 262-267, 1984. PubMed: 6425217

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Restrictions

This cell line was deposited at the ATCC by Donna G. Sieckmann, Naval Medical Research Center. The line is distributed for academic research purposes only. The Naval Medical Research Center releases the line subject to the following: 1.) The line or its products must not be distributed to third parties. Commercial interests are the exclusive property of the Naval Medical Research Center. 2.) Any proposed commercial use of the cell line including any use by a for-profit entity must first be negotiated with the Commanding Officer, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500.

References

Galloway DR, et al. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 44: 262-267, 1984. PubMed: 6425217